Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Forecasted Growth Rate and Market Size of the Traumatic Brain Injury Biomarkers Market?
The market size for biomarkers in the treatment of traumatic brain injury has experienced substantial growth in recent history. Its value is projected to increase from $1.13 billion in 2024 to reach $1.38 billion in 2025, indicating a compound annual growth rate (CAGR) of 22.1%. Factors contributing to this growth during the historical period include an uptick in road accidents, heightened public consciousness about brain health, an increase in emergency room visits, a surge in military-related TBI cases, and an expansion in diagnostic alternatives.
It is anticipated that the market size for traumatic brain injury biomarkers will experience significant expansion in the coming years, reaching $3.03 billion by 2029 with a 21.7% compound annual growth rate (CAGR). This projected growth throughout the forecast period can be accredited to the increasing need for immediate diagnostic tools, amplified investment in research regarding the brain, surges in personalized medicine adoption, the enlargement of clinical trials regarding brain injury biomarkers and augmented healthcare expenditures. Key trends within the forecast period take into account advances in proteomic platforms technology, new developments in detecting biomarkers from blood, invention of movable diagnostic devices, exploration and progression in neuroinflammation markers, and the integration of biomarker analysis with artificial intelligence.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27438&type=smp
Which Factor Is Shaping The Future Of The Traumatic Brain Injury Biomarkers Market?
As the occurrence of road traffic mishaps is on the rise, it is predicted to fuel the expansion of the traumatic brain injury biomarkers industry. These mishaps, often occurring unexpectedly and requiring immediate medical attention, are increasing due to the surge in private vehicle usage brought on by urbanization and motorization. The vital role played by traumatic brain injury biomarkers in such incidents is by enabling quick and precise evaluations of head damages. They assist in ensuring sooner diagnosis by identifying specific blood proteins, providing vital input for clinicians to make treatment decisions quickly, thereby improving emergency patient outcomes. For example, a report on road safety by the Luxembourg-based regulatory authority, European Commission, stated that in May 2024, the total road fatalities rose to 20,634 in 2022, up from 19,917 in 2021. Hence, the increasing incidence of road traffic accidents is fostering the growth of the traumatic brain injury biomarkers market. In addition, the growing adoption of personalized medicine forms a major driving force for the traumatic brain injury biomarkers market’s growth. Personalized medicine aims to customize treatments for individual patients considering their genetic, environmental, and lifestyle factors to maximize outcomes and enhance care. The appeal of personalized medicine is growing due to advancements in genomic technologies that allow precise identification of genetic variations and custom-made treatments for individuals. Traumatic brain injury biomarkers are beneficial in this segment by identifying specific biological indicators tied to brain injuries. Implementing such biomarkers allows personalized treatment plans that enhance recovery outcomes and optimize clinical decision-making for each patient. For example, the US-based nonprofit organization, the Personalized Medicine Coalition (PMC), reported in February 2024, that the U.S. Food and Drug Administration (FDA) sanctioned 26 new personalized medicines in 2023, a considerable rise from 12 approved in 2022. Thus, the growing preference for personalized medicine is propelling the growth of the traumatic brain injury biomarkers market.
What Is The Segment-Wise Breakdown Of The Traumatic Brain Injury Biomarkers Market?
The traumatic brain injury biomarkers market covered in this report is segmented
1) By Type: Protein Biomarkers, Genetic Biomarkers, Metabolomic Biomarkers
2) By Sample Type: Blood-based, Cerebrospinal Fluid (CSF)-Based, Urine-Based
3) By Application: Diagnosis, Prognosis, Monitoring Treatment Response
4) By End Use: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes
Subsegments:
1) By Protein Biomarkers: Glial Fibrillary Acidic Protein (GFAP), Ubiquitin C-Terminal Hydrolase L1 (UCH-L1), S100 Calcium Binding Protein B (S100B), Neuron-Specific Enolase (NSE)
2) By Genetic Biomarkers: Apolipoprotein E (APOE) Genotyping, Brain-Derived Neurotrophic Factor (BDNF) Polymorphism, Interleukin-6 (IL-6) Gene Variants, Tumor Necrosis Factor-Alpha (TNF-a) Polymorphism
3) By Metabolomic Biomarkers: Lactate, Creatine, Choline, N-Acetylaspartate (NAA)
Which Trends Are Redefining The Future Landscape Of The Traumatic Brain Injury Biomarkers Industry?
Leading companies involved in the market for traumatic brain injury biomarkers are honing their attention on creating innovative methods like a lab-based blood test to enhance the accuracy and rapidity of concussion assessments and diagnoses. This kind of test is a diagnostic instrument that gauges specific biomarkers in blood to determine the presence and severity of brain damage, allowing for quicker and more fact-based decision making in clinical settings. For instance, in June 2025, Abbott Laboratories, a US healthcare firm, introduced the Alinity i and Architect i1000SR lab tests. These tests exhibit the determination of two crucial biomarkers, GFAP and UCH-L1, which aid medical professionals in assessing possible concussions within 12 hours of the injury occurring. Furthermore, these tests provide lab results in a mere 18 minutes, facilitating faster triage decisions in emergencies, and minimizing dependency on superfluous CT scans. This breakthrough offers doctors a trustworthy means to identify patients possibly suffering from traumatic brain injuries, exemplifying significant progress in widening accessibility to swift, data-based care in emergency situations.
Which Companies Hold The Largest Market Share In The Traumatic Brain Injury Biomarkers Sector?
Major companies operating in the traumatic brain injury biomarkers market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Biogen Inc., BioMérieux S.A., DiaSorin S.p.A., Abcam Limited, Fujirebio Inc., Meso Scale Diagnostics (MSD), Olink Holding AB, Quanterix Corporation, OriGene Technologies Inc., BioDirection Inc., NanoDx Inc., BrainScope Company Inc., BrainBox Solutions Inc., DiaGenic ASA, NeuroTrauma Sciences LLC, and Banyan Biomarkers Inc.
Get The Full Report Here:
How Does Regional Performance Compare Across The Traumatic Brain Injury Biomarkers Industry?
North America was the largest region in the traumatic brain injury biomarkers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the traumatic brain injury biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=27438&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model